Patent 7776524 was granted and assigned to Genzyme on August, 2010 by the United States Patent and Trademark Office.
Methods and compositions are provided for detecting the presence of nucleic acid sequence variants in a subpopulation of nucleic acid molecules in a biological sample. These methods are particularly useful for identifying individuals with mutations indicative of cancer.